SIGA Technologies, Inc. (NASDAQ:SIGA – Get Free Report) saw unusually large options trading on Wednesday. Stock traders bought 1,200 call options on the company. This is an increase of approximately 1,438% compared to the typical daily volume of 78 call options.
Hedge Funds Weigh In On SIGA Technologies
A number of large investors have recently bought and sold shares of the business. Teacher Retirement System of Texas grew its holdings in shares of SIGA Technologies by 19.9% during the fourth quarter. Teacher Retirement System of Texas now owns 12,829 shares of the company’s stock valued at $77,000 after purchasing an additional 2,126 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in SIGA Technologies during the 4th quarter valued at approximately $78,000. EP Wealth Advisors LLC grew its stake in SIGA Technologies by 14.5% during the 4th quarter. EP Wealth Advisors LLC now owns 13,887 shares of the company’s stock worth $83,000 after buying an additional 1,755 shares during the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in SIGA Technologies in the fourth quarter worth $83,000. Finally, XTX Topco Ltd bought a new stake in SIGA Technologies in the third quarter valued at $85,000. Institutional investors own 55.40% of the company’s stock.
SIGA Technologies Trading Down 2.0 %
Shares of SIGA opened at $5.92 on Thursday. SIGA Technologies has a 52 week low of $4.95 and a 52 week high of $12.83. The firm has a market cap of $422.91 million, a price-to-earnings ratio of 4.93 and a beta of 1.03. The stock has a 50 day moving average of $5.75 and a 200-day moving average of $6.27.
SIGA Technologies Announces Dividend
The firm also recently disclosed a special dividend, which will be paid on Thursday, May 15th. Investors of record on Tuesday, April 29th will be paid a dividend of $0.60 per share. The ex-dividend date is Tuesday, April 29th.
SIGA Technologies Company Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than SIGA Technologies
- How to Buy Gold Stock and Invest in Gold
- Viking Therapeutics Stock Pops But Struggles to Hold Gains
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Qualcomm Stock Just Earned a Fresh Buy Rating—Get Excited
- Profitably Trade Stocks at 52-Week Highs
- Meta Stock Holds Upside Potential as Analysts Cut Price Targets
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.